I have a very quick comment. I think federal leadership is critical. Let me give you the example of London, Ontario, which has a neuroendocrine tumour program that patients were going to from everywhere in Canada. Now it's prohibited from doing that. We cannot see patients from out of province because of the funding issue.
I think the need for a centre of excellence is absolutely critical, and that has to come from the federal level, particularly for rare disorders.
Once again, this is a huge opportunity for Canada to redefine its health care system in the 21st century.